MORGAN STANLEY PLC/CALL/MERCK & CO./140/0.1/21.03.25 Share Price

Warrant

DE000MB5BXV7

Real-time Bid/Ask 06:36:27 08/07/2024 pm IST
0.45 EUR / 0.47 EUR +9.52% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./140/0.1/21.03.25
Current month-26.32%
1 month-27.59%
Date Price Change
08/24/08 0.45 +7.14%
05/24/05 0.42 +5.00%
04/24/04 0.4 -9.09%
03/24/03 0.44 -13.73%
02/24/02 0.51 -3.77%

Delayed Quote Börse Stuttgart

Last update July 08, 2024 at 01:14 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB5BXV
ISINDE000MB5BXV7
Date issued 05/04/2023
Strike 140 $
Maturity 21/03/2025 (256 Days)
Parity 10 : 1
Emission price 0.58
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.87
Lowest since issue 0.107
Spread 0.02
Spread %4.26%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus